Stage 4 — Generate solutions. Select all nursing actions that belong in Mr. K's individualized comfort-care plan at this time.
Select All That Apply
Choose your responses, then check the answer.
Explanation
Why options 2, 4, 5, and 6 fit Option 2 uses the prescribed alternate route for dyspnea when swallowing is unsafe and requires reassessment. Option 4 protects against aspiration while relieving dry mouth. Option 5 uses low-burden positioning, comfort-beneficial oxygen, and an individualized antisecretory trial rather than promising elimination of all sound. Option 6 makes family communication concurrent clinical care.
Why options 1 and 3 fail Repeated deep suctioning can add trauma and distress and is not warranted simply to remove death-rattle sound. Tests and antibiotics are not automatically prohibited, but starting them solely for an abnormal number without weighing reversible symptom benefit, burdens, and the documented goals is not individualized care.
Symptom relief Use behavioral evidence of dyspnea or pain, a route the client can tolerate, and prompt reassessment. Opioids may relieve end-of-life breathlessness. Oxygen is continued here because he has chronic lung disease, symptomatic hypoxemia, and an existing oxygen plan, but comfort rather than saturation normalization is the goal.
Secretions Explain that noisy pooled secretions often distress family more than the dying person. Repositioning and mouth care come first; a prescribed antimuscarinic trial may be considered and monitored for benefit and adverse effects.
Communication Do not postpone explanation until after treatment. Tell the family what the nurse sees, what is being done, and how response will be judged.
Scenario (Stage 4 — Generate solutions)The nurse now converts the analysis into a goal-concordant care bundle.
Clinical judgment targetSelect route-safe symptom relief and concurrent family support without treating DNR as abandonment of care.
Opioid for end-of-life dyspnea — A prescribed opioid may reduce the sensation and observable burden of breathlessness; dose and route are individualized and response and adverse effects are reassessed.
Antimuscarinic trial — A prescribed medication such as glycopyrrolate may be tried for distressing noisy secretions, with monitoring because benefit varies and dry mouth, retention, or other adverse effects can occur.
Comfort-beneficial oxygen — Oxygen is not started routinely for every dying person with breathlessness; it may be continued or offered when symptomatic hypoxemia is known or suspected and observed comfort improves.